Global and China Prescription Dermatological Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Sep-2020
No. of pages: 128
Inquire Before Buying

Prescription Dermatological Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Dermatological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Prescription Dermatological Drugs market is segmented into

- Anti-acne Drugs

- Anti-aging Drugs

- Dermatitis Drugs

- Hair Loss Drugs

- Psoriasis Drugs

- Skin Cancer Drugs

- Melasma Drugs

- Seborrhea Drugs

Segment by Application, the Prescription Dermatological Drugs market is segmented into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Regional and Country-level Analysis

The Prescription Dermatological Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Prescription Dermatological Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Prescription Dermatological Drugs Market Share Analysis

Prescription Dermatological Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prescription Dermatological Drugs business, the date to enter into the Prescription Dermatological Drugs market, Prescription Dermatological Drugs product introduction, recent developments, etc.

The major vendors covered:

- Johnson & Johnson

- Merck

- Bayer

- Mylan Pharmaceuticals

- Pfizer

- F. Hoffmann-La Roche

- Allergan

- Bausch Health

- PharmaDerm Pharmaceuticals

- Allergan Inamed Corporation

Global and China Prescription Dermatological Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Prescription Dermatological Drugs Product Introduction
1.2 Market Segments
1.3 Key Prescription Dermatological Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type
1.4.2 Anti-acne Drugs
1.4.3 Anti-aging Drugs
1.4.4 Dermatitis Drugs
1.4.5 Hair Loss Drugs
1.4.6 Psoriasis Drugs
1.4.7 Skin Cancer Drugs
1.4.8 Melasma Drugs
1.4.9 Seborrhea Drugs
1.5 Market by Application
1.5.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Prescription Dermatological Drugs Market Size, Estimates and Forecasts
2.1.1 Global Prescription Dermatological Drugs Revenue 2015-2026
2.1.2 Global Prescription Dermatological Drugs Sales 2015-2026
2.2 Global Prescription Dermatological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Prescription Dermatological Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Prescription Dermatological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Prescription Dermatological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Prescription Dermatological Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Prescription Dermatological Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Prescription Dermatological Drugs Revenue Forecast by Region (2021-2026)
3 Global Prescription Dermatological Drugs Competitor Landscape by Players
3.1 Global Top Prescription Dermatological Drugs Sales by Manufacturers
3.1.1 Global Prescription Dermatological Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Prescription Dermatological Drugs Manufacturers by Revenue
3.2.1 Global Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prescription Dermatological Drugs Revenue in 2019
3.2.5 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Prescription Dermatological Drugs Price by Manufacturers
3.4 Global Prescription Dermatological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prescription Dermatological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prescription Dermatological Drugs Market Size by Type (2015-2020)
4.1.1 Global Prescription Dermatological Drugs Sales by Type (2015-2020)
4.1.2 Global Prescription Dermatological Drugs Revenue by Type (2015-2020)
4.1.3 Prescription Dermatological Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prescription Dermatological Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Prescription Dermatological Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Prescription Dermatological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prescription Dermatological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Prescription Dermatological Drugs Market Size by Application (2015-2020)
5.1.1 Global Prescription Dermatological Drugs Sales by Application (2015-2020)
5.1.2 Global Prescription Dermatological Drugs Revenue by Application (2015-2020)
5.1.3 Prescription Dermatological Drugs Price by Application (2015-2020)
5.2 Prescription Dermatological Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Prescription Dermatological Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Prescription Dermatological Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Prescription Dermatological Drugs Market Size YoY Growth 2015-2026
6.1.1 China Prescription Dermatological Drugs Sales YoY Growth 2015-2026
6.1.2 China Prescription Dermatological Drugs Revenue YoY Growth 2015-2026
6.1.3 China Prescription Dermatological Drugs Market Share in Global Market 2015-2026
6.2 China Prescription Dermatological Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Prescription Dermatological Drugs Players by Sales (2015-2020)
6.2.2 China Top Prescription Dermatological Drugs Players by Revenue (2015-2020)
6.3 China Prescription Dermatological Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Prescription Dermatological Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Prescription Dermatological Drugs Price by Type (2015-2020)
6.4 China Prescription Dermatological Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Prescription Dermatological Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Prescription Dermatological Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Prescription Dermatological Drugs Price Forecast by Type (2021-2026)
6.5 China Prescription Dermatological Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Prescription Dermatological Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Prescription Dermatological Drugs Price by Application (2015-2020)
6.6 China Prescription Dermatological Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Prescription Dermatological Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Prescription Dermatological Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Prescription Dermatological Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Prescription Dermatological Drugs Market Size YoY Growth 2015-2026
7.2 North America Prescription Dermatological Drugs Market Facts & Figures by Country
7.2.1 North America Prescription Dermatological Drugs Sales by Country (2015-2020)
7.2.2 North America Prescription Dermatological Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Prescription Dermatological Drugs Market Size YoY Growth 2015-2026
8.2 Europe Prescription Dermatological Drugs Market Facts & Figures by Country
8.2.1 Europe Prescription Dermatological Drugs Sales by Country
8.2.2 Europe Prescription Dermatological Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Prescription Dermatological Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Prescription Dermatological Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Prescription Dermatological Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Prescription Dermatological Drugs Market Facts & Figures by Country
10.2.1 Latin America Prescription Dermatological Drugs Sales by Country
10.2.2 Latin America Prescription Dermatological Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Prescription Dermatological Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
11.2.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Description and Business Overview
12.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Prescription Dermatological Drugs Products Offered
12.2.5 Merck Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Prescription Dermatological Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Corporation Information
12.4.2 Mylan Pharmaceuticals Description and Business Overview
12.4.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
12.4.5 Mylan Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Prescription Dermatological Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Corporation Information
12.6.2 F. Hoffmann-La Roche Description and Business Overview
12.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.6.4 F. Hoffmann-La Roche Prescription Dermatological Drugs Products Offered
12.6.5 F. Hoffmann-La Roche Recent Development
12.7 Allergan
12.7.1 Allergan Corporation Information
12.7.2 Allergan Description and Business Overview
12.7.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Allergan Prescription Dermatological Drugs Products Offered
12.7.5 Allergan Recent Development
12.8 Bausch Health
12.8.1 Bausch Health Corporation Information
12.8.2 Bausch Health Description and Business Overview
12.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
12.8.5 Bausch Health Recent Development
12.9 PharmaDerm Pharmaceuticals
12.9.1 PharmaDerm Pharmaceuticals Corporation Information
12.9.2 PharmaDerm Pharmaceuticals Description and Business Overview
12.9.3 PharmaDerm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
12.9.5 PharmaDerm Pharmaceuticals Recent Development
12.10 Allergan Inamed Corporation
12.10.1 Allergan Inamed Corporation Corporation Information
12.10.2 Allergan Inamed Corporation Description and Business Overview
12.10.3 Allergan Inamed Corporation Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
12.10.5 Allergan Inamed Corporation Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Description and Business Overview
12.11.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
12.11.5 Johnson & Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Prescription Dermatological Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prescription Dermatological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Prescription Dermatological Drugs Market Segments
Table 2. Ranking of Global Top Prescription Dermatological Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prescription Dermatological Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anti-acne Drugs
Table 5. Major Manufacturers of Anti-aging Drugs
Table 6. Major Manufacturers of Dermatitis Drugs
Table 7. Major Manufacturers of Hair Loss Drugs
Table 8. Major Manufacturers of Psoriasis Drugs
Table 9. Major Manufacturers of Skin Cancer Drugs
Table 10. Major Manufacturers of Melasma Drugs
Table 11. Major Manufacturers of Seborrhea Drugs
Table 12. Global Prescription Dermatological Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Prescription Dermatological Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Prescription Dermatological Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Prescription Dermatological Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Prescription Dermatological Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Prescription Dermatological Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 18. Global Prescription Dermatological Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Prescription Dermatological Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatological Drugs as of 2019)
Table 22. Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Prescription Dermatological Drugs Price (2015-2020) (USD/Units)
Table 25. Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Prescription Dermatological Drugs Product Type
Table 27. Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 30. Global Prescription Dermatological Drugs Sales Share by Type (2015-2020)
Table 31. Global Prescription Dermatological Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Prescription Dermatological Drugs Revenue Share by Type (2015-2020)
Table 33. Prescription Dermatological Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Units)
Table 34. Global Prescription Dermatological Drugs Sales Share by Type (2021-2026)
Table 35. Global Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 36. Global Prescription Dermatological Drugs Sales Share by Application (2015-2020)
Table 37. Global Prescription Dermatological Drugs Sales Share by Application (2021-2026)
Table 38. Global Prescription Dermatological Drugs Sales Market Share Forecast by Application (2021-2026)
Table 39. Global Prescription Dermatological Drugs Revenue by Application (2015-2020) (US$ Million)
Table 40. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 41. China Prescription Dermatological Drugs Sales (K Units) of Key Companies (2015-2020)
Table 42. China Prescription Dermatological Drugs Sales Share by Company (2015-2020)
Table 43. China Prescription Dermatological Drugs Revenue (US$ Million) by Company (2015-2020)
Table 44. China Prescription Dermatological Drugs Sales (K Units) by Type (2015-2020)
Table 45. China Prescription Dermatological Drugs Sales Share by Type (2015-2020)
Table 46. China Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 47. China Prescription Dermatological Drugs Price (K Units) by Type (2015-2020)
Table 48. China Prescription Dermatological Drugs Sales (K Units) by Type (2021-2026)
Table 49. China Prescription Dermatological Drugs Sales Share by Type (2021-2026)
Table 50. China Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 51. China Prescription Dermatological Drugs Revenue Share by Type (2021-2026)
Table 52. China Prescription Dermatological Drugs Price (K Units) by Type (2021-2026)
Table 53. China Prescription Dermatological Drugs Sales (K Units) by Application (2015-2020)
Table 54. China Prescription Dermatological Drugs Sales Share by Application (2015-2020)
Table 55. China Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 56. China Prescription Dermatological Drugs Sales (K Units) by Application (2021-2026)
Table 57. China Prescription Dermatological Drugs Sales Share by Application (2021-2026)
Table 58. China Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 59. China Prescription Dermatological Drugs Revenue Share by Application (2021-2026)
Table 60. North America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 61. North America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 62. North America Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. North America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 64. Europe Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 65. Europe Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 66. Europe Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 68. Asia Pacific Prescription Dermatological Drugs Sales by Region (2015-2020) (K Units)
Table 69. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Table 70. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2015-2020) (US$ Million)
Table 71. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Table 72. Latin America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 73. Latin America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 74. Latin Americaa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Latin America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 77. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 78. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 79. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Prescription Dermatological Drugs Product
Table 84. Johnson & Johnson Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 93. Bayer Product
Table 94. Bayer Recent Development
Table 95. Mylan Pharmaceuticals Corporation Information
Table 96. Mylan Pharmaceuticals Description and Business Overview
Table 97. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 98. Mylan Pharmaceuticals Product
Table 99. Mylan Pharmaceuticals Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 103. Pfizer Product
Table 104. Pfizer Recent Development
Table 105. F. Hoffmann-La Roche Corporation Information
Table 106. F. Hoffmann-La Roche Description and Business Overview
Table 107. F. Hoffmann-La Roche Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 108. F. Hoffmann-La Roche Product
Table 109. F. Hoffmann-La Roche Recent Development
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 113. Allergan Product
Table 114. Allergan Recent Development
Table 115. Bausch Health Corporation Information
Table 116. Bausch Health Description and Business Overview
Table 117. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 118. Bausch Health Product
Table 119. Bausch Health Recent Development
Table 120. PharmaDerm Pharmaceuticals Corporation Information
Table 121. PharmaDerm Pharmaceuticals Description and Business Overview
Table 122. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 123. PharmaDerm Pharmaceuticals Product
Table 124. PharmaDerm Pharmaceuticals Recent Development
Table 125. Allergan Inamed Corporation Corporation Information
Table 126. Allergan Inamed Corporation Description and Business Overview
Table 127. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 128. Allergan Inamed Corporation Product
Table 129. Allergan Inamed Corporation Recent Development
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Prescription Dermatological Drugs Players
Table 134. Prescription Dermatological Drugs Customers List
Table 135. Prescription Dermatological Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Dermatological Drugs Product Picture
Figure 2. Global Prescription Dermatological Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Prescription Dermatological Drugs Report Years Considered
Figure 16. Global Prescription Dermatological Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Prescription Dermatological Drugs Sales 2015-2026 (K Units)
Figure 18. Global Prescription Dermatological Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 21. Global Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 23. Global Prescription Dermatological Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Prescription Dermatological Drugs Revenue in 2019
Figure 25. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Prescription Dermatological Drugs Sales Market Share by Type in 2019
Figure 28. Global Prescription Dermatological Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Prescription Dermatological Drugs Revenue Market Share by Type in 2019
Figure 30. Global Prescription Dermatological Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Prescription Dermatological Drugs Sales Market Share by Application in 2019
Figure 33. Global Prescription Dermatological Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Prescription Dermatological Drugs Revenue Market Share by Application in 2019
Figure 35. China Prescription Dermatological Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 36. China Prescription Dermatological Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 37. China Prescription Dermatological Drugs Market Share in Global Market 2015-2026
Figure 38. China 5 and 10 Largest Prescription Dermatological Drugs Players Market Share by Revenue in Prescription Dermatological Drugs in 2019
Figure 39. China Prescription Dermatological Drugs Revenue Share by Type (2015-2020)
Figure 40. China Prescription Dermatological Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 41. China Prescription Dermatological Drugs Revenue Share by Application (2015-2020)
Figure 42. China Prescription Dermatological Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 43. North America Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. North America Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. North America Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 46. North America Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 47. U.S. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.S. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Canada Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Canada Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Europe Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 52. Europe Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 53. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 54. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 55. Germany Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Germany Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. France Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. France Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. U.K. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. U.K. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Italy Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Italy Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Russia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Russia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Asia Pacific Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 66. Asia Pacific Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 67. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 68. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 69. China Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. China Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Japan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Japan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. South Korea Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. South Korea Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. India Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. India Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Australia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Australia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Taiwan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Taiwan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Indonesia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Indonesia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Thailand Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Thailand Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Malaysia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Malaysia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Philippines Prescription Dermatological Drugs Sales Growth
  • Global Medical Cannabis Oil Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Medical Cannabis Oil market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Cannabis Oil business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Cannabis Oil market by ......
  • Global Medical Use Empty Capsules Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the Medical Use Empty Capsules market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Use Empty Capsules business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Use Empty C......
  • Global Systemic Lupus Erythematosus (SLE) Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Systemic Lupus Erythematosus (SLE) Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Systemic Lupus Erythematosus (SLE) Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growt......
  • Global Pets Vitamins and Supplements Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Pets Vitamins and Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pets Vitamins and Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pets Vitamins......
  • Global Soft Elastic Capsule Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Soft Elastic Capsule market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Soft Elastic Capsule business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Soft Elastic Capsule market by ......
  • Global Anti-worm Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Anti-worm Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-worm Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-worm Medication market by ......
  • Global Albendazole Anthelmintic Drug Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Albendazole Anthelmintic Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albendazole Anthelmintic Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Albendazole A......
  • Global Immune System Supplements Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 138
    According to this study, over the next five years the Immune System Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Immune System Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Immune System Supplements market......
  • Global Antipyretic Analgesics Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Antipyretic Analgesics market will register a 1.3%% CAGR in terms of revenue, the global market size will reach $ 2693.6 million by 2025, from $ 2561.5 million in 2019. In particular, this report presents the global revenue market share of key companies in Antipyretic Analgesics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Analgesics market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs